---
title: AMSbiopharma vs Sannova
slug_a: amsbiopharma
slug_b: sannova
site: cro
review_signal_gate: closed
canonical_path: /compare/amsbiopharma/sannova
---

# AMSbiopharma vs Sannova

Side-by-side profile data from each company listing on this directory.

## AMSbiopharma

- Profile: [/companies/amsbiopharma](/companies/amsbiopharma)

AMSbiopharma — Analytical CRO providing comprehensive analytical services for drug research, preclinical development, and quality control across pharmaceutical and biopharmaceutical industries.

Services: 3. Modalities: 0. Indications: 0. Locations: 0. Certifications: 2. The strongest documented coverage currently appears in services (3).

### Services

- Preclinical In Vitro Studies
- Analytical Method Development & Validation
- ICH Stability Studies

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)

### Sourcing models

- Data not yet provided.

## Sannova

- Profile: [/companies/sannova](/companies/sannova)

Sannova — Sannova provides bioanalytical and analytical CRO services, including immunogenicity and ligand binding assays, PK testing, DMPK services, extractables and leachables, nitrosamine testing, and pharmaceutical stability testing. Its listed work spans small molecules, biologics and biosimilars, and cell and gene therapies.

Services: 9. Modalities: 5. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Preclinical In Vitro Studies
- In Vitro ADME / DMPK
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Analytical Method Development & Validation
- ICH Stability Studies
- Proteomics Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)

### Sourcing models

- Data not yet provided.